David Sinclair is a tenured Professor of Genetics at Harvard Medical School. He is best known for his work on genes and small molecules that delay and reverse aging by boosting the body’s defenses and gene therapies to rejuvenate tissues. He has published over 200 scientific papers, is a co-inventor on over 50 patent and patent applications and has co-founded biotechnology companies in the areas of metabolic diseases, inflammation, vaccines, infectious disease detection, eye diseases, diabetes, fertility, cancer, and biosecurity. In 2019, his book Lifespan became a New York Times best seller. He is Co-Chief Editor of the scientific journal Aging and has received 36 awards, including the Australian Medical Research Medal, the Merck Prize, the NIH Director’s Pioneer award, TIME magazine’s list of the “100 most influential people in the world,” and TIME’s “Top 50 people in healthcare.” In 2018, he became Officer of the Order of Australia for his work in medical research, science communication, and national security.